A comparative trial of Kampo formulas on insulin resistance and endothelial function

A comparative trial of Kampo formulas on insulin resistance and endothelial function - Effect of Kampo formulas on endothelial function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004551

Enrollment

130

Registered

2010-11-15

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis or metabolic syndrome

Interventions

Oral administration of keishibukuryogan Non-administration of keishibukuryogan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with rheumatoid arthritis. 2. Patients with factors of metabolic syndrome (obesity, elevation of blood pressure, lipid abnormality, hyperglycemia etc.).

Exclusion criteria

Exclusion criteria: 1. Patients with inflammatory diseases (except rheumatoid arthritis), cancer or other serious disorders. 2. Patients who changed addiction medicines within three months.

Design outcomes

Primary

Measure	Time frame
The levels of peripheral arterial tonometry	—

Countries

Japan

Contacts

Public ContactYutaka Nagata

University of Toyama Department of Japanese Oriental Medicine, Graduate school of Medicine and Pharmaceutical Sciences

076-434-7393

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026